HF
ABEO icon

HRT Financial’s Abeona Therapeutics ABEO Stock Holding History

HRT Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-96,655
Closed -$460K – 2505
2025
Q1 		$460K Buy
+96,655
New +$526K ﹤0.01% 1511
2024
Q2 		– Sell
-69,051
Closed -$500K – 2126
2024
Q1 		$500K Buy
+69,051
New +$438K ﹤0.01% 1259
2022
Q2 		– Sell
-3,962
Closed -$31K – 2841
2022
Q1 		$31K Buy
+3,962
New +$27.2K ﹤0.01% 2784
2021
Q4 		– Sell
-7,701
Closed -$215K – 3074
2021
Q3 		$215K Buy
7,701
+468
+6% +$15K ﹤0.01% 2637
2021
Q2 		$282K Buy
+7,233
New +$295K ﹤0.01% 2176
2020
Q1 		– Sell
-1,116
Closed -$91K – 715
2019
Q4 		$91K Buy
+1,116
New +$78.7K ﹤0.01% 1037

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

HRT Financial's ABEO Position: Q2 2025 in Review

HRT Financial sold out of Abeona Therapeutics (ABEO) in Q2 2025, closing a stake of 96,655 shares — an estimated $460K sold.

HRT Financial first reported a position in ABEO in Q4 2019 and held it in 6 quarters. The position peaked at $500K in Q1 2024. 95 funds tracked by Wall St. Rank hold ABEO as of Q2 2025.

  • HRT Financial reported no remaining Abeona Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 96,655 Abeona Therapeutics shares in Q2 2025, an estimated $460K.
  • HRT Financial first reported a position in Abeona Therapeutics in Q4 2019 and held it in 6 quarters.
  • HRT Financial's Abeona Therapeutics position peaked at $500K in Q1 2024.
  • 95 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.